X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
humans (4) 4
index medicus (4) 4
cancer (3) 3
colorectal neoplasms - drug therapy (3) 3
colorectal neoplasms - mortality (3) 3
colorectal neoplasms - pathology (3) 3
female (3) 3
life sciences (3) 3
male (3) 3
middle aged (3) 3
oncology (3) 3
treatment outcome (3) 3
1st-line treatment (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
adult (2) 2
aged, 80 and over (2) 2
angiopoietin-2 (2) 2
angiopoietin-2 - blood (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
bevacizumab (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - analogs & derivatives (2) 2
capecitabine (2) 2
colorectal cancer (2) 2
colorectal neoplasms - blood (2) 2
deoxycytidine - administration & dosage (2) 2
deoxycytidine - analogs & derivatives (2) 2
disease-free survival (2) 2
fluorouracil - administration & dosage (2) 2
fluorouracil - analogs & derivatives (2) 2
gastroenterology (2) 2
leucovorin - administration & dosage (2) 2
liver neoplasms - drug therapy (2) 2
liver neoplasms - mortality (2) 2
liver neoplasms - secondary (2) 2
organoplatinum compounds - administration & dosage (2) 2
oxaliplatin (2) 2
prognosis (2) 2
research article (2) 2
retrospective studies (2) 2
[ sdv ] life sciences [q-bio] (1) 1
activation (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
angiogenesis (1) 1
article (1) 1
bevacizumab - administration & dosage (1) 1
bile duct neoplasms - drug therapy (1) 1
bile duct neoplasms - pathology (1) 1
bile ducts, extrahepatic - pathology (1) 1
bile ducts, intrahepatic - pathology (1) 1
biomarkers (1) 1
biomarkers, tumor - blood (1) 1
cancer research (1) 1
cancer therapies (1) 1
carboplatin - administration & dosage (1) 1
cell lung-cancer (1) 1
cell-cycle progression (1) 1
cetuximab (1) 1
cetuximab plus irinotecan (1) 1
chemotherapy (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
clinical trials (1) 1
clinical trials, phase ii as topic (1) 1
cohort studies (1) 1
colon-cancer (1) 1
colorectal neoplasms - metabolism (1) 1
combination (1) 1
combination chemotherapy (1) 1
combined modality therapy (1) 1
consent (1) 1
controlled-trial (1) 1
disease (1) 1
drug therapy (1) 1
efficacy (1) 1
egfr (1) 1
enzyme-linked immunosorbent assay (1) 1
epidermal-growth-factor (1) 1
fluorouracil failure (1) 1
folfiri3 (1) 1
follow-up studies (1) 1
gall-bladder cancer (1) 1
gallbladder neoplasms - drug therapy (1) 1
gallbladder neoplasms - pathology (1) 1
gastroenterology & hepatology (1) 1
gastroenterology and hepatology (1) 1
gemcitabine plus carboplatin (1) 1
genetics (1) 1
hematology, oncology and palliative medicine (1) 1
hepatic resection (1) 1
immunoenzyme techniques (1) 1
in-vivo (1) 1
irinotecan (1) 1
kaplan-meier estimate (1) 1
kras (1) 1
leucovorin (1) 1
liver (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Colorectal Cancer, ISSN 1533-0028, 2013, Volume 12, Issue 1, pp. 28 - 36
Micro-Abstract Half of patients with KRAS wild-type colorectal cancer do not benefit from adding anti–epithelial growth factor receptor (EGFR) to standard... 
Hematology, Oncology and Palliative Medicine | Gastroenterology and Hepatology | Signal transducer and activator of transcription 3 (STAT3) | KRAS | Cetuximab | EGFR | Colorectal cancer | 1ST-LINE TREATMENT | ACTIVATION | CELL-CYCLE PROGRESSION | PHASE-III TRIAL | MUTATION STATUS | ONCOLOGY | EPIDERMAL-GROWTH-FACTOR | CETUXIMAB PLUS IRINOTECAN | NON-HODGKINS-LYMPHOMA | TRANSCRIPTION FACTOR | SIGNAL TRANSDUCER | ras Proteins - genetics | Phosphorylation | Proto-Oncogene Proteins p21(ras) | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Liver Neoplasms - mortality | Immunoenzyme Techniques | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Retrospective Studies | Liver Neoplasms - secondary | Colorectal Neoplasms - metabolism | STAT3 Transcription Factor - metabolism | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Signal Transduction | Liver Neoplasms - drug therapy | Proto-Oncogene Proteins - genetics | Survival Rate | Mutation - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Liver Neoplasms - metabolism | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 08/2014, Volume 14, Issue 1, pp. 143 - 143
Journal Article
BMC cancer, ISSN 1471-2407, 12/2013, Volume 13, Issue 1, pp. 611 - 611
Journal Article
Journal Article
Clinical Colorectal Cancer, ISSN 1533-0028, 03/2013, Volume 12, Issue 1, pp. A2 - A3
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.